Pharmacokinetic changes in Riociguat before and after catheterizatio
- Conditions
- CTEPH
- Registration Number
- JPRN-jRCT1041200111
- Lead Sponsor
- Tatsuguchi Mariko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Patients who meet all of the following criteria are included.
1. Patients aged 20 to 80
2. Patients diagnosed with CTEPH
3.Patients who are planning to undergo BPA and are taking the therapeutic drug riociguat
4. Persons who have obtained consent for this research by signing the consent form
Patients who fall under any of the following will not be included in this study.
1. Persons with serious liver disease
2. Persons with serious kidney disease
3. Women who are pregnant or may become pregnant
4. Lactating women
5. Other persons who are judged to be inappropriate by the principal investigator and the coordinator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method